US8835561023 - Common Stock
THERMO FISHER SCIENTIFIC INC
NYSE:TMO (4/19/2024, 6:56:46 PM)
After market: 543 -1.78 (-0.33%)544.78
+3.26 (+0.6%)
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. The company is headquartered in Waltham, Massachusetts and currently employs 130,000 full-time employees. The Company’s Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment provides an offering of instruments and the supporting consumables, software and services that are used for a range of applications. The Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments, and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial and food safety laboratories. The Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. Its brands include Thermo Scientific, Applied Biosystems, and others. The company also provides regulatory-grade, real-world evidence for approved medical treatments and therapies.
THERMO FISHER SCIENTIFIC INC
168 Third Avenue
Waltham MASSACHUSETTS 02451
P: 17816221000
CEO: Marc N. Casper
Employees: 130000
Website: https://www.thermofisher.com/
Although the market may be grumbling over certain issues, concerned investors can trust these healthcare stocks to deliver the goods.
Thermo Fisher layoffs are in the news Tuesday after the company announced plans to cut 74 jobs at its plasmid manufacturing location.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Thermo Fisher (NYSE:TMO) layoffs are in the news Tuesday after the biopharma se...
The US Federal Trade Commission warned hundreds of companies including Pfizer Inc., Baxter International Inc. and Thermo Fisher Scientific Inc. that it could challenge their acquisitions even after the deadline for the agency’s antitrust review had passed.
Here you can normally see the latest stock twits on TMO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: